SecSonar.com

Jupiter Neurosciences, Inc. (JUNS)

Jupiter Neurosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Jupiter Neurosciences, Inc. (JUNS) is a Biotechnology company based in US with a market capitalization of $9.5M. Free cash flow was negative at -$5.4M. This page tracks JUNS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4 employees · IPO Jan 18, 2022

Valuation

Valuation & price

$0.34 · as of May 17, 2026 · -88.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.97$1.59$0.20Jul 25Dec 25Jun 26Jul 7, 25$1.47Jul 9, 25$1.61Jul 11, 25$2.29Jul 15, 25$2.97Jul 17, 25$1.72Jul 21, 25$1.77Jul 23, 25$1.73Jul 25, 25$1.62Jul 29, 25$1.41Jul 31, 25$1.40Aug 4, 25$1.50Aug 6, 25$1.22Aug 8, 25$1.21Aug 12, 25$1.11Aug 14, 25$1.34Aug 19, 25$1.29Aug 21, 25$1.48Aug 25, 25$1.44Aug 27, 25$1.49Aug 29, 25$1.47Sep 3, 25$1.24Sep 5, 25$1.23Sep 9, 25$1.39Sep 11, 25$1.56Sep 15, 25$1.60Sep 17, 25$1.49Sep 19, 25$1.43Sep 23, 25$1.35Sep 25, 25$1.40Sep 29, 25$1.80Oct 2, 25$1.72Oct 6, 25$1.54Oct 8, 25$1.59Oct 10, 25$1.53Oct 14, 25$1.51Oct 16, 25$1.63Oct 20, 25$1.58Oct 22, 25$1.49Oct 24, 25$1.53Oct 28, 25$1.70Oct 30, 25$1.38Nov 3, 25$1.32Nov 5, 25$1.36Nov 7, 25$1.33Nov 11, 25$1.33Nov 14, 25$1.34Nov 18, 25$1.25Nov 20, 25$1.23Nov 24, 25$1.17Nov 26, 25$1.21Dec 1, 25$1.20Dec 3, 25$1.21Dec 5, 25$1.14Dec 9, 25$1.13Dec 11, 25$1.18Dec 15, 25$1.08Dec 17, 25$1.13Dec 19, 25$1.10Dec 23, 25$1.07Dec 26, 25$1.14Dec 31, 25$1.02Jan 5, 26$1.04Jan 7, 26$1.05Jan 9, 26$1.06Jan 13, 26$0.93Jan 15, 26$0.86Jan 20, 26$0.90Jan 22, 26$0.94Jan 26, 26$0.82Jan 28, 26$0.63Jan 30, 26$0.53Feb 3, 26$0.57Feb 5, 26$0.62Feb 9, 26$0.62Feb 11, 26$0.61Feb 17, 26$0.56Feb 19, 26$0.56Feb 23, 26$0.52Feb 25, 26$0.60Feb 27, 26$0.53Mar 3, 26$0.47Mar 5, 26$0.42Mar 9, 26$0.42Mar 11, 26$0.40Mar 13, 26$0.42Mar 17, 26$0.39Mar 19, 26$0.38Mar 23, 26$0.40Mar 25, 26$0.35Mar 27, 26$0.35Apr 1, 26$0.38Apr 6, 26$0.34Apr 8, 26$0.37Apr 10, 26$0.40Apr 14, 26$0.39Apr 16, 26$0.40Apr 20, 26$0.46Apr 22, 26$0.45Apr 24, 26$0.39Apr 28, 26$0.37Apr 30, 26$0.38May 4, 26$0.40May 6, 26$0.36May 8, 26$0.33May 12, 26$0.33May 15, 26$0.34May 19, 26$0.32May 21, 26$0.27May 26, 26$0.23May 28, 26$0.29Jun 1, 26$0.26Jun 3, 26$0.25Jun 5, 26$0.24Jun 9, 26$0.23Jun 11, 26$0.23Jun 15, 26$0.24Jun 17, 26$0.23Jun 22, 26$0.23Jun 24, 26$0.25Jun 30, 26$0.20
$0.2052-week range$2.97
Loading valuation history…

Fundamentals

Key fundamentals

$9.5M

Market cap

—

Revenue growth (YoY)

80.6%

Gross margin

-$5.4M

Free cash flow (USD)

$1.5M

Net debt

20.3%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$1.1MFY 2021$638.0KFY 2022$233.3KFY 2023$0.00FY 2024$0.00FY 2025$21.8K
$0$21.8K

Free cash flow by year

2019 → 2025

FY 2019$-143.0KFY 2020$-254.8KFY 2021$-1.7MFY 2022$-1.2MFY 2023$-481.0KFY 2024$-3.9MFY 2025$-5.4M
-$143K-$5.4M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 202580.6%
100.0%80.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.06)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector AppointmentJun 30, 2026Filing
  • 8-K eventDirector ResignationJun 22, 2026Filing
  • 8-K eventExecutive AppointmentJun 5, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 21, 2026Filing
  • 8-K eventLicensing Agreement ProposedMay 20, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • FinancingSecurities RegistrationApr 16, 2026Filing
  • Annual report10-K FiledApr 1, 2026Filing

Questions

Frequently asked questions

What is Jupiter Neurosciences, Inc.'s market cap?

Jupiter Neurosciences, Inc. (JUNS) has a market capitalization of $9.5M.

What is JUNS's P/E ratio?

A meaningful P/E ratio is not available for JUNS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Jupiter Neurosciences, Inc. last report earnings?

JUNS last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying JUNS stock?

SEC Form 4 filings show no open-market insider buys at Jupiter Neurosciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ICU

SeaStar Medical Holding Corporation

$10.5M

IMRN

Immuron Limited

$8.5M

OSRH

OSR Holdings, Inc.

$10.8M

SYBX

Synlogic, Inc.

$7.8M

AIMD

Ainos, Inc.

$11.4M

VYNE

VYNE Therapeutics Inc.

$11.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.